Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rPA-102 Vaccine in Healthy Adult Volunteers
NCT00100724Phase 2Completed
- Sponsor
- diadexus
- Start
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rPA102 in anthrax, sponsored by diadexus. Started Apr 2004; status: completed.
02
Drugs
rPA102
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT00100724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100724.